Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Total Liabilities came in at $24.5 million in Q1 2026, up 22.68% YoY from $19.9 million in Q1 2025, and up 4.41% on a QoQ basis from $23.4 million in Q4 2025.
Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Total Liabilities data on file, last reported at $24.5 million in Q1 2026.
- Quarterly Total Liabilities rose 22.68% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.5 million (up 22.68% YoY) and the FY2025 annual result came in at $23.4 million, up 14.82% from the prior year.
- Total Liabilities grew to $24.5 million in Q1 2026, from $23.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $24.5 million in Q1 2026 to a low of $6.3 million in Q1 2023.
- A 5-year average of $15.7 million and a median of $16.4 million in 2024 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 158.56% in 2023, down 19.55% in 2023.
- Tracing TYRA's Total Liabilities over 5 years: stood at $8.4 million in 2022, then surged by 158.56% to $21.6 million in 2023, then decreased by 5.5% to $20.4 million in 2024, then grew by 14.82% to $23.4 million in 2025, then increased by 4.41% to $24.5 million in 2026.
- The last three Total Liabilities figures came in at $24.5 million (Q1 2026), $23.4 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | 29.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.70 Mn |
| Mar 31, 2026 | 24.47 Mn |
| Dec 31, 2025 | 23.43 Mn |
| Sep 30, 2025 | 21.34 Mn |
| Jun 30, 2025 | 19.35 Mn |
| Mar 31, 2025 | 19.94 Mn |
| Dec 31, 2024 | 20.41 Mn |
| Sep 30, 2024 | 18.30 Mn |
| Jun 30, 2024 | 16.42 Mn |
| Mar 31, 2024 | 14.86 Mn |
| Dec 31, 2023 | 21.60 Mn |
| Sep 30, 2023 | 16.19 Mn |
| Jun 30, 2023 | 11.44 Mn |
| Mar 31, 2023 | 6.27 Mn |
| Dec 31, 2022 | 8.35 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 7.79 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 6.24 Mn |